Your news and updates from the Division of
View this email in your browser

September 2019 Newsletter

Message from Paul Dorian

From Left to Right: Liz Pimentel and her daughter, Paul Dorian and his wife Sally

Reflections on 12 years as Division Director

It has been my privilege to be the Division Director in Cardiology since January 2007. As you are all aware, Susanna Mak has taken over as DDD since September 1st, and has already provided tremendous energy, creativity, and dedication to her role.

Over the past more than decade, I have come to meet with and know personally all members of the Division of Cardiology. It has been an honor and privilege to get to know and work with an extraordinary group of dedicated professionals, and I can say without equivocation that every single member of our Division is devoted to excellence in clinical care, education of our future colleagues, and a collaborative spirit both within our Division and with colleagues in the Department of Medicine and others in the Faculty of Medicine at our various hospitals.

The vast majority of our division members are engaged in many activities apart from outstanding clinical care, including research in all of its manifestations, education at every level of learner and trainee, a multitude of innovative and impactful creative professional activities, administration both at the University and the teaching hospitals, and contributions to developing quality in clinical practice, evaluation of care, and educational scholarship.

The Division is distinguished by extraordinary depth and breadth of the skill of our Faculty, and is recognized nationally and internationally for the value that we collectively provide to the shared enterprise.

Our size, depth and breadth is our biggest challenge. Over the past decade, I have personally witnessed a remarkable increase in collegial and collaborative activities in research and education, an increase in communication and sharing of best practices both academic and clinical, and a flowering of friendly and open communication. If I may be so bold, we have our younger colleagues in their first few decades of practice to thank in large part for this wonderful development. Senior colleagues have been highly supportive of these developments, whilst we are all aware of the challenges posed by increasing workloads, greater patient complexity, new and innovative but complex and difficult procedures, and a substantial growth in the size and complexity of the clinical and educational enterprise.

I am deeply grateful for all those in the Division who have contributed so importantly to our collaborative and shared goal of excellence delivered with a kind heart.

Paul Dorian
Cardiology Department Division Director, 2007 - 2019


Cardiology Training Program

C3 Farewell Dinner

Seated from left to right: Liz Pimental (residency program admin), Abdul Al-Hesayen (site director, St. Michael’s Hospital, Susanna Mak (DDD incoming), Victoria Korley (Program Director), Shaheeda Ahmen (site director, Sunnybrook Hospital). Standing from left to right: Brian Li, Vincent Siu, Will Chan, Paul Dorian (DDD), Jenn Amadio, Barbara Doumaras, Garry Thomas, Edison Wang, Abdul Al-Riyami

In the academic cycle, summer is a wonderful opportunity for a break from the full schedule of the fall and winter, and also a time of renewal for the program. The program hosts both a C3 farewell and a C1 welcome dinner. Paul Dorian also hosted his final Welcome BBQ as the DDD for all of our trainees and teachers engaged in their education. He and Sally have opened their home to the program annually for 12 years. Big shoes to fill!

C1 Welcome Dinner

Top row (left to right): George Hanna, Susanna Mak, Paul Dorian, Victoria Korley, Shaheeda Ahmed, Liz Pimentel, Abdul Al-Hesayen, Fotis Katsikeris, Anna Zavodni. Bottom row (left to right): Daniel Ozier, Spencer Lalonde, Scott Barichello.   Absent: Mena Gawarges, John Janevski

Each year, we welcome our new team of Cardiology Residents joining the program. We have the opportunity to host them for dinner and start a relationship that will see them become colleagues. Please extend your warmest welcome!

Fundraising and Advancement

The Division of Cardiology at Sunnybrook contributed to a fund in honour of our late colleague, Dr. Jack Tu. Many members pledged to contribute annually for 2 years and over $20,000 was raised in the first year to support the education of Jack’s son. Jack's impact on cardiovascular medicine and research extended well beyond Toronto, well across the world. If you or a colleague would like to learn more, please contact Dr. Bradley Strauss, Division Head for Cardiology at Sunnybrook, 
The Dr. Paul Dorian Cardiology Resident Research and Education Fund: This year, portions from the Dr. Paul Dorian Cardiology Resident Research and Education Fund will go to support online cardiology board review materials. The program conducted a needs survey of our trainees, and this ranked first among their recommendations.

A sincere thank you to everyone who has contributed to the fund. This fund continues to be our opportunity as a division to recognize the tremendous work that Dr. Dorian has done for Cardiology during his tenure as DDD, and to pay it forward to support city-wide education for our trainees and faculty members committed to learning opportunities within and across our academic hospitals. I am encouraging all faculty to consider this fund when deciding on worthy causes for your generosity.

If you would like to contribute, Gifts can be made directly here.

Upcoming Events


February 10, 2020: Division Wide Career Health Day Details to come!
May 21, 2020: Ursula Bangs Resident Research Day and Ken Brown Lectureship Speaker:  Dr. Heather Ross


Publication Highlights

1.            Salvage MitraClip in severe secondary mitral regurgitation complicating acute myocardial infarction: data from a multicentre international study.  Haberman D, Taramasso M, Czarnecki A, Kerner A, Chrissoheris M, Spargias K, Poles L, Agmon Y, Scianna S, Beeri R, Lotan C, Maisano F, Shuvy M. Eur J Heart Fail. 2019 Sep;21(9):1161-1164. doi: 10.1002/ejhf.1565. Epub 2019 Aug 5. No abstract available. pubmed
2.            Vascular Complications and Procedures Following Transcatheter Aortic Valve Implantation. Raju S, Eisenberg N, Montbriand J, Cusimano RJ, Feindel C, Ouzounian M, Horlick E, Osten M, Tsang W, Roche-Nagle G.  Eur J Vasc Endovasc Surg. 2019 Sep;58(3):437-444. doi: 10.1016/j.ejvs.2019.03.014. Epub 2019 Jul 18. pubmed
3.            Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial. Fitchett D, Inzucchi SE, Wanner C, Mattheus M, George JT, Vedin O, Zinman B, Johansen OE.  Eur Heart J. 2019 Aug 31. pii: ehz621. doi: 10.1093/eurheartj/ehz621. [Epub ahead of print] pubmed
4.            Thiamin supplementation does not improve left ventricular ejection fraction in ambulatory heart failure patients: a randomized controlled trial.  Keith M, Quach S, Ahmed M, Azizi-Namini P, Al-Hesayen A, Azevedo E, James R, Leong-Poi H, Ong G, Desjardins S, Lee PJ, Ravamehr-Lake D, Yan AT.Am J Clin Nutr. 2019 Aug 27. pii: nqz192. doi: 10.1093/ajcn/nqz192. [Epub ahead of print] pubmed
5.            SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.   Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S. Cell Metab. 2019 Aug 27. pii: S1550-4131(19)30444-9. doi: 10.1016/j.cmet.2019.08.015. [Epub ahead of print] pubmed
6.            Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.  Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA; EMPA-HEART CardioLink-6 Investigators. Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375. [Epub ahead of print] pubmed
7.            Evaluation of cardiac hypertrophy in the setting of sudden cardiac death. Cunningham KS, Spears DA, Care M.    Forensic Sci Res. 2019 Aug 19;4(3):223-240. doi: 10.1080/20961790.2019.1633761. eCollection 2019. Review. pubmed
8.            1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry.  Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, Weber M, Yzeiraj E, Schiavi D, Mangieri A, Vaskelyte L, Alessandrini H, Deuschl F, Brugger N, Ahmad H, Biasco L, Orban M, Deseive S, Braun D, Rommel KP, Pozzoli A, Frerker C, Näbauer M, et al. JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461. doi: 10.1016/j.jcin.2019.04.019. pubmed
9.            Forgotten Valve Meets Neglected Organ: Cardiohepatic Interactions After Transcatheter Tricuspid Valve Repair.     Fam NP  JACC Cardiovasc Interv. 2019 Aug 12;12(15):1421-1422. doi: 10.1016/j.jcin.2019.05.002. Epub 2019 May 21. No abstract available. pubmed
10.          Trends in the Use of Cardiac Imaging for Patients With Heart Failure in Canada. Braga JR, Leong-Poi H, Rac VE, Austin PC, Ross HJ, Lee DS. JAMA Netw Open. 2019 Aug 2;2(8):e198766. doi: 10.1001/jamanetworkopen.2019.8766.      pubmed
11.          Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes. Garg V, Verma S, Connelly K. Prog Cardiovasc Dis. 2019 Aug 2. pii: S0033-0620(19)30102-1. doi: 10.1016/j.pcad.2019.07.005. [Epub ahead of print] Review. pubmed
12.          Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry. Fanaroff AC, Vora AN, Chen AY, Mathews R, Udell JA, Roe MT, Thomas LE, Wang TY. Am Heart J. 2019 Aug;214:184-193. doi: 10.1016/j.ahj.2019.05.011. Epub 2019 May 25. pubmed
13.          European Society of Hypertension Working Group on Blood Pressure Monitoring. Validation protocols for blood pressure measuring devices: the impact of the European Society of Hypertension International Protocol and the development of a Universal Standard. O'Brien E, Stergiou G, Palatini P, Asmar R, Ioannidis JP, Kollias A, Lacy P, McManus RJ, Myers MG, Shennan A, Wang J, Parati G; Blood Press Monit. 2019 Aug;24(4):163-166. doi: 10.1097/MBP.0000000000000391.pubmed
14.          Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. Rivard L, Khairy P, Talajic M, Tardif JC, Nattel S, Bherer L, Black S, Healey J, Lanthier S, Andrade J, Massoud F, Nault I, Guertin MC, Dorian P, Kouz S, Essebag V, Ellenbogen KA, Wyse G, Racine N, Macle L, Mondesert B, Dyrda K, et al. Can J Cardiol. 2019 Aug;35(8):1069-1077. doi: 10.1016/j.cjca.2019.04.022. Epub 2019 May 7. pubmed
15.          Modality Selection for the Revascularization of Left Main Disease.  Tam DY, Bakaeen F, Feldman DN, Kolh P, Lanza GA, Ruel M, Piccolo R, Fremes SE, Gaudino M.Can J Cardiol. 2019 Aug;35(8):983-992. doi: 10.1016/j.cjca.2018.12.017. Epub 2018 Dec 15. Review.  pubmed
16.          Association of left ventricular size with regional right ventricular mechanics in Hypoplastic Left Heart Syndrome.  Forsha D, Li L, Joseph N, Kutty S, Friedberg MK. Int J Cardiol. 2019 Aug 1. pii: S0167-5273(19)33278-4. doi: 10.1016/j.ijcard.2019.07.090. [Epub ahead of print] pubmed
17.          Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation.  Shurrab M, Ko DT, McElhaney J, Henderson M, Danon A, Quinn KL, O'Donnell D, Crystal E, Newman D.  J Am Med Dir Assoc. 2019 Aug;20(8):984-987. doi: 10.1016/j.jamda.2019.01.131. Epub 2019 Mar 8. pubmed
18.          Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy. Mathur S, Dreisbach JG, Karur GR, Iwanochko RM, Morel CF, Wasim S, Nguyen ET, Wintersperger BJ, Hanneman K.J Cardiovasc Magn Reson. 2019 Aug 1;21(1):45. doi: 10.1186/s12968-019-0557-0. pubmed
19.          Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.   Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, et al.  Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:.  Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21. pubmed
20.          The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease. Godoy LC, Ko DT, Rao V, Farkouh ME. Prog Cardiovasc Dis. 2019 Aug 1. pii: S0033-0620(19)30101-X. doi: 10.1016/j.pcad.2019.07.004. [Epub ahead of print] Review. pubmed
21.          Health care utilization prior to out-of-hospital cardiac arrest: A population-based study.Resuscitation. Shuvy M, Koh M, Qiu F, Brooks SC, Chan TCY, Cheskes S, Dorian P, Geri G, Lin S, Scales DC, Ko DT.          2019 Aug;141:158-165. doi: 10.1016/j.resuscitation.2019.04.033. Epub 2019 Apr 27. pubmed
22.          Gene discovery: From biological plausibility to genetic evidence supporting disease causation. Heart Rhythm.  Gollob MH. 2019 Jul 29. pii: S1547-5271(19)30671-X. doi: 10.1016/j.hrthm.2019.07.030. [Epub ahead of print] No abstract available. pubmed
23.          Growth differentiation factor 15 is decreased by kidney transplantation.      Connelly PW, Yan AT, Nash MM, Lok CE, Gunaratnam L, Prasad GVR. Clin Biochem. 2019 Jul 27. pii: S0009-9120(19)30418-7. doi: 10.1016/j.clinbiochem.2019.07.013. [Epub ahead of print]pubmed
24.          Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. Bohula EA, Katz JN, van Diepen S, Alviar CL, Baird-Zars VM, Park JG, Barnett CF, Bhattal G, Barsness GW, Burke JA, Cremer PC, Cruz J, Daniels LB, DeFilippis A, Granger CB, Hollenberg S, Horowitz JM, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, et al.   JAMA Cardiol. 2019 Jul 24. doi: 10.1001/jamacardio.2019.2467. [Epub ahead of print]pubmed
25.          Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.  Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM.  Eur Heart J. 2019 Jul 18. pii: ehz460. doi: 10.1093/eurheartj/ehz460. [Epub ahead of print] pubmed
26.          Vascular-ventricular coupling during exercise is not affected by exaggerated blood pressures in endurance-trained athletes.  Currie KD, Sasson Z, Goodman JM.      J Appl Physiol (1985). 2019 Jul 18. doi: 10.1152/japplphysiol.00108.2019. [Epub ahead of print]     pubmed
27.          Effect of Alirocumab on Mortality After Acute Coronary Syndromes.  Steg PG, Szarek M, Bhatt DL, Bittner VA, Brégeault MF, Dalby AJ, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Ostadal P, Parkhomenko A, Pordy R, Roe MT, Tricoci P, Vogel R, White HD, et al.  Circulation. 2019 Jul 9;140(2):103-112. doi: 10.1161/CIRCULATIONAHA.118.038840. Epub 2019 May 23. Erratum in: Circulation. 2019 Jul 23;140(4):e171. pubmed
28.          Association of Surrogate Decision-making Interventions for Critically Ill Adults With Patient, Family, and Resource Use Outcomes: A Systematic Review and Meta-analysis.  Bibas L, Peretz-Larochelle M, Adhikari NK, Goldfarb MJ, Luk A, Englesakis M, Detsky ME, Lawler PR. JAMA Netw Open. 2019 Jul 3;2(7):e197229. doi: 10.1001/jamanetworkopen.2019.7229. pubmed
29.          PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design.  Vehmeijer JT, Koyak Z, Zwinderman AH, Harris L, Peinado R, Oechslin EN, Silversides CK, Bouma BJ, Budts W, van Gelder IC, Oliver JM, Mulder BJM, de Groot JR.  Neth Heart J. 2019 Jul 3. doi: 10.1007/s12471-019-1297-3. [Epub ahead of print]pubmed
30.          Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology.      Bonaca MP, Olenchock BA, Salem JE, Wiviott SD, Ederhy S, Cohen A, Stewart GC, Choueiri TK, Di Carli M, Allenbach Y, Kumbhani DJ, Heinzerling L, Amiri-Kordestani L, Lyon AR, Thavendiranathan P, Padera R, Lichtman A, Liu PP, Johnson DB, Moslehi J.  Circulation. 2019 Jul 2;140(2):80-91. pubmed
31.          The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes.  Woo V, Connelly K, Lin P, McFarlane P. Curr Med Res Opin. 2019 Jul;35(7):1283-1295. doi: 10.1080/03007995.2019.1576479. Epub 2019 Feb 15. pubmed
32.          Quantification of myocardial deformation by deformable registration-based analysis of cine MRI: validation with tagged CMR.  Lamacie MM, Houbois CP, Greiser A, Jolly MP, Thavendiranathan P, Wintersperger BJ.  Eur Radiol. 2019 Jul;29(7):3658-3668. doi: 10.1007/s00330-019-06019-9. Epub 2019 Feb 15. pubmed
33.          Did This Patient Have Cardiac Syncope?: The Rational Clinical Examination Systematic Review. Albassam OT, Redelmeier RJ, Shadowitz S, Husain AM, Simel D, Etchells EE.  JAMA. 2019 Jun 25;321(24):2448-2457. doi: 10.1001/jama.2019.8001.   pubmed
34.          Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.  van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, Knight JD, Lopes RD, Cowper PA, Mark DB, Alexander JH. J Thorac Cardiovasc Surg. 2019 Jun 21. pii: S0022-5223(19)31278-4. doi: 10.1016/j.jtcvs.2019.06.020. [Epub ahead of print]pubmed
35.          Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database. Tam DY, Rocha RV, Wijeysundera HC, Austin PC, Dvir D, Fremes SE.J Thorac Cardiovasc Surg. 2019 Jun 17. pii: S0022-5223(19)31207-3. doi: 10.1016/j.jtcvs.2019.05.081. [Epub ahead of print] pubmed
36.          Cardiovascular Magnetic Resonance Imaging: Identifying the Effects of Cancer Therapy.  Houbois CP, Thavendiranathan P, Wintersperger BJ.  J Thorac Imaging. 2019 Jun 17. doi: 10.1097/RTI.0000000000000430. [Epub ahead of print]     pubmed
37.          Cardiotoxicity of Immune Checkpoint Inhibitors.               Zhang L, Jones-O'Connor M, Awadalla M, Zlotoff DA, Thavendiranathan P, Groarke JD, Villani AC, Lyon AR, Neilan TG.  Curr Treat Options Cardiovasc Med. 2019 Jun 8;21(7):32. doi: 10.1007/s11936-019-0731-6. Review. Pubmed
38.          Hemodynamic Aspects of Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiac Support: A Worldwide Survey.  Siriwardena M, Dozois M, Fan E, Billia F.  ASAIO J. 2019 Jun 5. doi: 10.1097/MAT.0000000000001024. [Epub ahead of print] pubmed
39.          Information on Cardiovascular Disease in the Digital Era: Results From a Cross-Sectional Patient Survey. Coomes EA, Haghbayan H, Finken LR, Quadros KK, Bagai A, Cheema AN.         Can J Cardiol. 2019 Jun;35(6):791-794. doi: 10.1016/j.cjca.2019.03.015. Epub 2019 Mar 20. pubmed
40.          Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.  Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Kerneis M, Diallo A, Vicaut E, Montalescot G; ATLANTIC investigators. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E369-E377. doi: 10.1002/ccd.27921. Epub 2018 Oct 9. pubmed
41.          Corrigendum to 'The Ross procedure versus mechanical aortic valve replacement in young patients: a decision analysis'.  Tam DY, Wijeysundera HC, Ouzounian M, Fremes SE.  [Eur J Cardiothorac Surg 2019;55:1180--6]. Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1241. doi: 10.1093/ejcts/ezz018. No abstract available. pubmed
42.          The Ross procedure versus mechanical aortic valve replacement in young patients: a decision analysis. Tam DY, Wijeysundera HC, Ouzounian M, Fremes SE.  Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1180-1186. doi: 10.1093/ejcts/ezy414. pubmed
43.          Pregnancy in women with pre-existent ischaemic heart disease: a systematic review with individualised patient data. Heart.  Lameijer H, Burchill LJ, Baris L, Ruys TP, Roos-Hesselink JW, Mulder BJM, Silversides CK, van Veldhuisen DJ, Pieper PG. 2019 Jun;105(11):873-880. doi: 10.1136/heartjnl-2018-314364. Epub 2019 Feb 21. Review.        Pubmed
44.          Global lessons for quality care: a tale of two countries. Lee EY, Yan AT. Heart. 2019 Jun;105(11):812-813. doi: 10.1136/heartjnl-2018-314624. Epub 2019 Feb 7. No abstract available. pubmed
45.          Right ventricular fibrosis is associated with cardiac remodelling after pulmonary valve replacement.  Yamamura K, Yuen D, Hickey EJ, He X, Chaturvedi RR, Friedberg MK, Grosse-Wortmann L, Hanneman K, Billia F, Farkouh ME, Wald RM. Heart. 2019 Jun;105(11):855-863. doi: 10.1136/heartjnl-2018-313961. Epub 2018 Dec 4. Pubmed
46.          Role of Mitochondrial Aldehyde Dehydrogenase in Nitroglycerin-Mediated Vasodilation: Observations Concerning the Dose-Response Relationship.  He JD, Lytvyn Y, Zhou K, Parker JD.J Cardiovasc Pharmacol. 2019 Jun;73(6):359-364. doi: 10.1097/FJC.0000000000000673. pubmed
47.          Methodological Issues in Determining the Accuracy of Automated Office Blood Pressure Readings for Diagnosing Hypertension-Reply.      Roerecke M, Kaczorowski J, Myers MG.                JAMA Intern Med. 2019 Jun 1;179(6):850-851. doi: 10.1001/jamainternmed.2019.1221. No abstract available. pubmed
48.          International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.  Pereira NL, So D, Bae JH, Chavez I, Jeong MH, Kim SW, Madan M, Graham J, O'Cochlain F, Pauley N, Lennon RJ, Bailey K, Hasan A, Baudhuin LM, Bell MR, Lerman A, Goodman S, Mathew V, Farkouh M, Rihal CS.  Pharmacogenet Genomics. 2019 Jun;29(4):76-83. doi: 10.1097/FPC.0000000000000368. pubmed
49.          Stroke in Patients With Peripheral Artery Disease.  Kolls BJ, Sapp S, Rockhold FW, Jordan JD, Dombrowski KE, Fowkes FGR, Mahaffey KW, Berger JS, Katona BG, Blomster JI, Norgren L, Abramson BL, Leiva-Pons JL, Prieto JC, Sokurenko G, Hiatt WR, Jones WS, Patel MR.  Stroke. 2019 Jun;50(6):1356-1363. doi: 10.1161/STROKEAHA.118.023534. Epub 2019 May 16.   pubmed


Copyright © 2019, Department of Medicine, University of Toronto, All rights reserved.

Contact us for Cardiology division newsletter submissions

Our mailing address is:
R. Fraser Elliott Bldg., 3-805
190 Elizabeth Street, Toronto, ON M5G 2C4

You can update your preferences or unsubscribe from this list

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
University of Toronto, Department of Medicine, Division of Cardiology · 600 University Avenue, Suite 1603 · Toronto, On M5G1X5 · Canada

Email Marketing Powered by Mailchimp